AIRDUO DIGIHALER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Airduo Digihaler, and when can generic versions of Airduo Digihaler launch?
Airduo Digihaler is a drug marketed by Teva Pharm and is included in one NDA. There are twenty-eight patents protecting this drug.
This drug has four hundred and eighty-seven patent family members in thirty-seven countries.
The generic ingredient in AIRDUO DIGIHALER is fluticasone propionate; salmeterol xinafoate. There are twenty-nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Airduo Digihaler
A generic version of AIRDUO DIGIHALER was approved as fluticasone propionate; salmeterol xinafoate by HIKMA on December 17th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AIRDUO DIGIHALER?
- What are the global sales for AIRDUO DIGIHALER?
- What is Average Wholesale Price for AIRDUO DIGIHALER?
Summary for AIRDUO DIGIHALER
International Patents: | 487 |
US Patents: | 28 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Drug Prices: | Drug price information for AIRDUO DIGIHALER |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for AIRDUO DIGIHALER |
What excipients (inactive ingredients) are in AIRDUO DIGIHALER? | AIRDUO DIGIHALER excipients list |
DailyMed Link: | AIRDUO DIGIHALER at DailyMed |
Pharmacology for AIRDUO DIGIHALER
Drug Class | Corticosteroid beta2-Adrenergic Agonist |
Mechanism of Action | Adrenergic beta2-Agonists Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for AIRDUO DIGIHALER
AIRDUO DIGIHALER is protected by twenty-eight US patents and two FDA Regulatory Exclusivities.
Patents protecting AIRDUO DIGIHALER
Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Airflow adaptor for a breath-actuated dry powder inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dry powder inhalation apparatus
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics and power management
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Inhalation device with integrated electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Drug delivery device with electronics
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dry powder inhalation apparatus
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Airflow adaptor for a breath-actuated dry powder inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dry powder inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dry powder inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dry powder inhalation apparatus
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Process for preparing a medicament
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Dose counter for inhaler having a bore and shaft arrangement
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compliance monitoring module for a breath-actuated inhaler
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Process for preparing a medicament
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
FDA Regulatory Exclusivity protecting AIRDUO DIGIHALER
REVISIONS TO LABELING BASED ON DATA SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST
Exclusivity Expiration: ⤷ Sign Up
PEDIATRIC EXCLUSIVITY
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-006 | Jul 12, 2019 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-005 | Jul 12, 2019 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-005 | Jul 12, 2019 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AIRDUO DIGIHALER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-005 | Jul 12, 2019 | ⤷ Sign Up | ⤷ Sign Up |
Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-006 | Jul 12, 2019 | ⤷ Sign Up | ⤷ Sign Up |
Teva Pharm | AIRDUO DIGIHALER | fluticasone propionate; salmeterol xinafoate | POWDER;INHALATION | 208799-004 | Jul 12, 2019 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for AIRDUO DIGIHALER
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Teva B.V. | Airexar Spiromax | salmeterol xinafoate, fluticasone propionate | EMEA/H/C/004267 Airexar Spiromax is indicated for use in adults aged 18 years and older only.AsthmaAirexar Spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist.Chronic Obstructive Pulmonary Disease (COPD)Airexar Spiromax is indicated for the symptomatic treatment of patients with COPD, with a FEV1 |
Withdrawn | no | no | no | 2016-08-18 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for AIRDUO DIGIHALER
See the table below for patents covering AIRDUO DIGIHALER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 105903107 | 用于吸入器的剂量计数器、吸入器及其轴 (DOSE COUNTERS FOR INHALERS, INHALERS AND SHAFTS THEREOF) | ⤷ Sign Up |
Eurasian Patent Organization | 201690641 | ИНКРЕМЕНТАЛЬНЫЙ СЧЕТЧИК ДОЗ ДЛЯ ИНГАЛЯТОРА ОТМЕРЕННЫХ ДОЗ | ⤷ Sign Up |
Denmark | 2596827 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for AIRDUO DIGIHALER
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1519731 | 92269 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
1305329 | SPC/GB08/026 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080116; UK EU/1/07/434/002 20080116; UK EU/1/07/434/003 20080116 |
2506844 | 2018C/022 | Belgium | ⤷ Sign Up | PRODUCT NAME: EEN FARMACEUTISCH COMBINATIEPRODUCT DAT EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN UMECLIDINIUM (BV. UMECLIDINIUMBROMIDE), VILANTEROL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN (BV. VILANTEROLTRIFENATAAT) EN FLUTICASONEFUROAAT OMVAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |